FDA Highlights – by Bruce Sylvester – Patients who received standard therapy for cystic fibrosis plus adjunctive inhaled dry powder mannitol have achieved sustained improvement in lung function… read more.
World Health Matters – Norway – by Gary Finnegan – Researchers in Norway have shown that physical therapy can have a significant impact on recovery times for patients… read more.
Scientists have identified 29 new genetic variants linked to multiple sclerosis, providing key insights into the biology of this very debilitating neurological disease. Many of the genes –… read more.
Multiple sclerosis (MS), a neurodegenerative disease, causes periodic attacks of neurologic symptoms such as limb weakness and mobility defects. And while MS patients’ walking abilities and muscle strength… read more.
Researchers from the University of Southampton, in collaboration with psychologists from six other universities, have started a study to assess the impact of a new psychological therapy for… read more.
Brief adherence programmes improve diabetes test results and depression symptoms. Patients simultaneously treated for both Type 2 diabetes and depression showed improved medication compliance and significantly improved blood… read more.
It is estimated that there are 2.9 million people in the UK diagnosed with diabetes1 and the incidence is increasing, as it is across the world, all the… read more.
by Dr Sunil Upadhyay – The incidence of small cell lung cancer accounts for nearly 15% of all diagnosed lung cancers. The majority present with locally advanced disease… read more.
by Dr Sunil Upadhyay – Malignant Pleural Mesothelioma (MPM) is of insidious onset and almost uniformly a fatal disease. Around 90% of the patients can be linked to… read more.
by Dr Sunil Upadhyay – Advanced non-small cell carcinoma of the lung represents one of the major unmet needs for an effective and prolonged survival outcome. The majority… read more.
by Dr Sunil Upadhyay – Since the publication of the iPASS trial data, gefitinib has become the treatment of choice in EGFR mutation positive tumours. However, almost all… read more.
by Dr Sunil Upadhyay – At the recently held 14th World Conference on Lung Cancer in Amsterdam, on behalf of the investigators, the randomised phase III clinical trial… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
